Evidence map›Paper›PMID 28086019›Full record

ArticleACS infectious diseases2017

HK2 Recruitment to Phospho-BAD Prevents Its Degradation, Promoting Warburg Glycolysis by Theileria-Transformed Leukocytes.

Malak Haidar, Anne Lombès, Frédéric Bouillaud, Eileen J Kennedy, Gordon Langsley

Open access · greenAbstract read
In one paragraph

Article in ACS infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Malak HaidarInserm U1016, CNRS UMR8104, Cochin Institute , Paris 75014 France.
Anne LombèsInserm U1016, CNRS UMR8104, Cochin Institute , Paris 75014 France.
Frédéric BouillaudInserm U1016, CNRS UMR8104, Cochin Institute , Paris 75014 France.
Eileen J KennedyDepartment of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia , Athens, Georgia 30602, United States.
Gordon LangsleyInserm U1016, CNRS UMR8104, Cochin Institute , Paris 75014 France.ORCID 0000-0001-6600-6286
Centre National de la Recherche Scientifique · FRDélégation Paris 5 · FRUniversity of Georgia · US

Funding

Targeted Inhibition of EGFR DimerizationR03CA188439 · NCI · UNIVERSITY OF GEORGIA · PI KENNEDY, EILEEN J · 2015 to 2016
$150k
NCI NIH HHS R03 CA188439
6 · The paper itself

Abstract

Theileria annulata infects bovine leukocytes, transforming them into invasive, cancer-like cells that cause the widespread disease called tropical theileriosis. We report that in Theileria-transformed leukocytes hexokinase-2 (HK2) binds to B cell lymphoma-2-associated death promoter (BAD) only when serine (S) 155 in BAD is phosphorylated. We show that HK2 recruitment to BAD is abolished by a cell-penetrating peptide that acts as a nonphosphorylatable BAD substrate that inhibits endogenous S155 phosphorylation, leading to complex dissociation and ubiquitination and degradation of HK2 by the proteasome. As HK2 is a critical enzyme involved in Warburg glycolysis, its loss forces Theileria-transformed macrophages to switch back to HK1-dependent oxidative glycolysis that down-regulates macrophage proliferation only when they are growing on glucose. When growing on galactose, degradation of HK2 has no effect on Theileria-infected leukocyte proliferation, because metabolism of this sugar is independent of hexokinases. Thus, targeted disruption of the phosphorylation-dependent HK2/BAD complex may represent a novel approach to control Theileria-transformed leukocyte proliferation.

Indexed as

Animalsbcl-Associated Death ProteinCattleCattle DiseasesCell-Penetrating PeptidesCell ProliferationGlycolysisHexokinaseLeukocytesPhosphorylationPromoter Regions, GeneticProteolysisSerineTheileria annulataTheileriasisbcl-Associated Death ProteinCell-Penetrating PeptidesHexokinaseSerineBADglycolysishexokinaseoxidative phosphorylationTheileriaWarburg

Identifiers

PMID28086019
PMCPMC5346052
OpenAlexW2579774566

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.